
Opinion|Videos|January 17, 2025
Key Unmet Needs in IPF and PPF
Author(s)Anna Podolanczuk, M.D., M.S.
Anna Podolanczuk, M.D., M.S., discusses the key unmet needs in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), and how artificial intelligence (AI) could play a transformative role in enabling earlier detection of these diseases in the future.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the key unmet needs in diagnosing IPF and PPF, and how do you see AI impacting earlier detection of the disease in the future?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
FDA approves combination therapy for blurry vision
3
Why the great pharma-MedTech divide is healthcare’s biggest miss
4
Medicaid expansion associated with lower overall breast cancer mortality
5


























